\u30b2\u30ce\u30e0\u533b\u5b66 II \uff08Genomic Medicine II\uff09\uff082024\u5e74\u5f8c\u671f\uff09
\u8b1b\u7fa9\u540d\u79f0\uff1a\u30b2\u30ce\u30e0\u533b\u5b66 II \uff08Genomic Medicine II\uff09
\u958b\u8b1b\u5e74\u5ea6\u30fb\u958b\u8b1b\u671f\uff1a\u30002024\u5e74\u5f8c\u671f
\u65e5\u6642\uff1a\u3000 PandA \u30aa\u30f3\u30c7\u30de\u30f3\u30c9
\u5834\u6240\uff1a\u3000\u30aa\u30f3\u30e9\u30a4\u30f3\uff08PandA\uff09
\u5358\u4f4d\u6570\uff1a\u30004<\/p>\n\n\n\n
(\u6388\u696d\u306e\u6982\u8981\u30fb\u76ee\u7684)DNA sequencing technology is increasingy popularized, the application of this technology in the clinical medicine is now coming into reality. The aim of this course is to provide knowledges which are necessary to understand Genomic Medicine. In this Genomic Medicine II, which is the latter half of the Genomic Medicine course through the year, the link between basic science and clinical medicine will be focused, from the currently ongoing practice to future perspectives. A lecture is provided by expert researcher each week.<\/p>\n\n\n\n
(\u5230\u9054\u76ee\u6a19)
\u2013 Understand the basic concepts behind Genomic Medicine
\u2013 Learn about current and upcoming application of genetic information in the clinical practice
\u2013 Learn about future perspectives of this field<\/p>\n\n\n\n
(\u6388\u696d\u8a08\u753b\u3068\u5185\u5bb9)<\/p>\n\n\n\n
\u201cEnhancer & Disease\u201d (Prof. Murakawa Yasuhiro)\u3000\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cGenome, Disease and Artificial Intelligence\u201d Assoc. Prof. Kawaguchi Shuji \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cHigh-Dimensional Statistical Methods: Challenges and Innovations\u201d
(Prof. Hung Hung,Institute of Epidemiology and Preventive Medicine, National Taiwan University) \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cAnalysis for highly polymorphic regions\u201d (Assoc.Prof. Kawaguchi Shuji)\u3000\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cGenetics of diseases: Structural Variants & Quantitative traits\u201d (Prof. Masao Nagasaki)\u3000\u3010Media class,ondemand type\u3011<\/p>\n\n\n\n
\u201cCOVID-19\u201d (Prof. Masao Nagasaki)\u3000\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cGenomic Database Resources for Rare Diseases\u201d (Prof. Masao Nagasaki)<\/p>\n\n\n\n
\u201cGenomics for Drug Discovery\u201d\uff08Prof. Yukinori Okada,Tokyo Univ.\uff09\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cPharmacogenomics\u201d (Dr. Taisei Mushiroda,Team leader, RIKEN Center for Integrative Medical Sciences)\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cBlockchain\u201d\uff08Dr. Mario Foglio \uff09\u3010Media class,on-demand type\u3011<\/p>\n\n\n\n
\u201cA condensed overview of methods in Infectious Disease Public Health\u201d\uff08Dr. PAUL, Richard,Institut Pasteur, Unit of Functional Genetics of Infectious Diseases\uff09\u3010Media class,on-demand type\u3011\u3000\u3000\u3000<\/p>\n\n\n\n
(\u5c65\u4fee\u8981\u4ef6)Student needs to have will to make use of genomics and other omics information into clinical medicine in the future.<\/p>\n\n\n\n
(\u6210\u7e3e\u8a55\u4fa1\u306e\u65b9\u6cd5\u30fb\u89b3\u70b9)Evaluated by submission assignments.<\/p>\n\n\n\n
(\u6559\u79d1\u66f8)\u6388\u696d\u4e2d\u306b\u6307\u793a\u3059\u308b Informed in class.<\/p>\n\n\n\n
(\u6388\u696d\u5916\u5b66\u4fee\uff08\u4e88\u7fd2\u30fb\u5fa9\u7fd2\uff09\u7b49)NA<\/p>\n\n\n\n
(\u305d\u306e\u4ed6\uff08\u30aa\u30d5\u30a3\u30b9\u30a2\u30ef\u30fc\u7b49\uff09) This class will be offered online.
\u30aa\u30d5\u30a3\u30b9\u30a2\u30ef\u30fc\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001KULASIS\u3067\u78ba\u8a8d\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u30b2\u30ce\u30e0\u533b\u5b66 II \uff08Genomic Medicine II\uff09\uff082024\u5e74\u5f8c\u671f\uff09\u8b1b … \u7d9a\u304d\u3092\u8aad\u3080